Not Yet Recruiting OBSERVATIONAL NCT07150598
Immune-Marker Platform for Patients With Advanced Lung Cancer (IMPALUX)
Sponsor: Deutsche Krebshilfe e.V., Bonn (Germany)
Conditions
NSCLC (Advanced Non-small Cell Lung Cancer) NSCLC Non-small Cell Lung Cancer NSCLC Stage IIIB~IV
Updated 1 time since 2025 Last updated: Sep 1, 2025 Started: Sep 1, 2025 Primary completion: Mar 31, 2027 Completion: Jun 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07150598, this observational or N/A phase trial focuses on NSCLC (Advanced Non-small Cell Lung Cancer) and NSCLC Non-small Cell Lung Cancer and remains actively recruiting participants. Sponsored by Deutsche Krebshilfe e.V., Bonn (Germany), it has been updated 1 time since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Not Yet Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Deutsche Krebshilfe e.V., Bonn (Germany)
- Technische Universität Dresden
- Universitätsklinikum Köln
Data source: Technische Universität Dresden
For direct contact, visit the study record on ClinicalTrials.gov .